文献速递血液净化与透析水电解质与酸碱

腹膜透析中酸碱调节的机制研究

Mechanisms of acid-base regulation in peritoneal dialysis.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该研究结合腹膜透析方案、全身体积描记法和肾功能研究,在小鼠中探究腹膜透析酸碱调节的分子机制。发现酸性透析液注入腹腔后pH快速升高并与血液平衡,碳酸酐酶介导的局部碳酸氢盐生成参与其中,而水通道蛋白-1缺失无影响;酸性透析液还增强肺和肾脏的酸排泄。

要点

  • 酸性腹膜透析液注入腹腔后pH快速升高至与血液平衡,中性生物相容性透析液pH保持恒定。
  • 碳酸酐酶抑制或基因缺失实验提示碳酸酐酶介导的局部碳酸氢盐生成参与酸性透析液引起的腹腔pH变化。
  • 酸性透析液可增强肺和肾脏的酸排泄,在肾衰竭患者中需考虑此效应。

核心结论

  • 腹膜透析期间腹腔pH变化由双向缓冲质转运和腹膜碳酸酐酶介导的碳酸氢盐生成共同介导。
  • 酸性透析液通过呼吸和肾脏反应增强酸排泄,在肾衰竭患者中应予以考虑。

研究设计与样本

  • 结合小鼠腹膜透析方案、全身体积描记法和肾功能研究的实验研究。

主要发现

  • 酸性透析液注入腹腔后pH在数分钟内升高至与血液pH快速平衡,而中性生物相容性透析液pH保持恒定。
  • 三孔模型预测局部碳酸氢盐生成至少部分解释酸性透析液引起的腹腔pH变化。
  • 腹膜膜中检测到碳酸酐酶亚型,乙酰唑胺抑制显著减少局部碳酸氢盐生成并延迟腹腔pH变化。
  • 水通道蛋白-1基因缺失对腹膜缓冲质转运和二氧化碳扩散无影响。
  • 酸性透析液增强肺和肾脏水平的酸排泄。

临床怎么用

  • 肾内科医生应认识到酸性腹膜透析液可增强肺和肾脏酸排泄,在肾衰竭患者中需综合评估酸碱状态。
  • 碳酸酐酶介导的局部碳酸氢盐生成是腹腔pH调节的重要机制,可能为优化腹膜透析酸碱管理提供靶点。

局限性

  • 研究仅在小鼠中进行,结论外推至人类需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peritoneal dialysis (PD) contributes to restore acid-base homeostasis in patients with end-stage renal disease. The transport pathways for buffers and carbon dioxide (CO2) across the peritoneal membrane remain poorly understood. METHODS: Combining well-established PD protocols, whole-body plethysmography and renal function studies in mice, we investigated molecular mechanisms of acid-base regulation in PD, including the potential role of the water channel aquaporin-1 (AQP1). RESULTS: After instillation in peritoneal cavity, the pH of acidic dialysis solutions increased within minutes to rapidly equilibrate with blood pH, whereas the neutral pH of biocompatible solutions remained constant. Predictions from the three-pore model of peritoneal transport suggested that local production of HCO3- accounts at least in part for the changes in intraperitoneal pH observed with acidic solutions. Carbonic anhydrase (CA) isoforms were evidenced in the peritoneal membrane and their inhibition with acetazolamide significantly decreased local production of HCO3- and delayed changes in intraperitoneal pH. On the contrary, genetic deletion of AQP1 had no effect on peritoneal transport of buffers and diffusion of CO2. Besides intraperitoneal modifications, the use of acidic dialysis solutions enhanced acid excretion both at pulmonary and renal levels. CONCLUSIONS: These findings suggest that changes in intraperitoneal pH during PD are mediated by bidirectional buffer transport and by CA-mediated production of HCO3- in the membrane. The use of acidic solutions enhances acid excretion through respiratory and renal responses, which should be considered in patients with renal failure.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Sow A, Morelle J, Hautem N, et al. Mechanisms of acid-base regulation in peritoneal dialysis. Nephrol Dial Transplant. 2018. PMID: 29186492. doi:10.1093/ndt/gfx307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。